{"nct_id":"NCT01682616","title":"A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma","status":"COMPLETED","status_verified_date":"2023-06","start_date":"2012-07-25","start_date_type":"ACTUAL","primary_completion_date":"2022-06-23","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-23","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}